197 related articles for article (PubMed ID: 27515131)
1. The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors.
Hutterer C; Hamilton S; Steingruber M; Zeitträger I; Bahsi H; Thuma N; Naing Z; Örfi Z; Örfi L; Socher E; Sticht H; Rawlinson W; Chou S; Haupt VJ; Marschall M
Antiviral Res; 2016 Oct; 134():130-143. PubMed ID: 27515131
[TBL] [Abstract][Full Text] [Related]
2. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
[TBL] [Abstract][Full Text] [Related]
3. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
Bigley TM; Reitsma JM; Terhune SS
J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
[TBL] [Abstract][Full Text] [Related]
5. Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity.
Hahn F; Hutterer C; Henry C; Hamilton ST; Strojan H; Kraut A; Schulte U; Schütz M; Kohrt S; Wangen C; Pfizer J; Couté Y; Rawlinson WD; Strobl S; Marschall M
Antiviral Res; 2018 Nov; 159():84-94. PubMed ID: 30268914
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.
Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
J Gen Virol; 2001 Jun; 82(Pt 6):1439-1450. PubMed ID: 11369889
[TBL] [Abstract][Full Text] [Related]
7. Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy.
Marschall M; Stein-Gerlach M; Freitag M; Kupfer R; van den Bogaard M; Stamminger T
J Gen Virol; 2002 May; 83(Pt 5):1013-1023. PubMed ID: 11961255
[TBL] [Abstract][Full Text] [Related]
8. Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.
Webel R; Hakki M; Prichard MN; Rawlinson WD; Marschall M; Chou S
J Virol; 2014 May; 88(9):4776-85. PubMed ID: 24522923
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo.
Schleiss M; Eickhoff J; Auerochs S; Leis M; Abele S; Rechter S; Choi Y; Anderson J; Scott G; Rawlinson W; Michel D; Ensminger S; Klebl B; Stamminger T; Marschall M
Antiviral Res; 2008 Jul; 79(1):49-61. PubMed ID: 18329738
[TBL] [Abstract][Full Text] [Related]
10. Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathways.
Komatsu TE; Pikis A; Naeger LK; Harrington PR
Antiviral Res; 2014 Jan; 101():12-25. PubMed ID: 24184129
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs).
Wild M; Kicuntod J; Seyler L; Wangen C; Bertzbach LD; Conradie AM; Kaufer BB; Wagner S; Michel D; Eickhoff J; Tsogoeva SB; Bäuerle T; Hahn F; Marschall M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430060
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.
Lischka P; Hewlett G; Wunberg T; Baumeister J; Paulsen D; Goldner T; Ruebsamen-Schaeff H; Zimmermann H
Antimicrob Agents Chemother; 2010 Mar; 54(3):1290-7. PubMed ID: 20047911
[TBL] [Abstract][Full Text] [Related]
13. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.
Reitsma JM; Savaryn JP; Faust K; Sato H; Halligan BD; Terhune SS
Cell Host Microbe; 2011 Feb; 9(2):103-14. PubMed ID: 21320693
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of novel quinazoline type inhibitors for mutant and wild-type EGFR and RICK kinases.
Breza N; Pato J; Orfi L; Hegymegi-Barakonyi B; Banhegyi P; Varkondi E; Borbely G; Petak I; Keri G
J Recept Signal Transduct Res; 2008; 28(4):361-73. PubMed ID: 18702009
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
[TBL] [Abstract][Full Text] [Related]
16. Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase.
Zimmermann A; Wilts H; Lenhardt M; Hahn M; Mertens T
Antiviral Res; 2000 Oct; 48(1):49-60. PubMed ID: 11080540
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity.
Hutterer C; Milbradt J; Hamilton S; Zaja M; Leban J; Henry C; Vitt D; Steingruber M; Sonntag E; Zeitträger I; Bahsi H; Stamminger T; Rawlinson W; Strobl S; Marschall M
Antiviral Res; 2017 Jul; 143():113-121. PubMed ID: 28400201
[TBL] [Abstract][Full Text] [Related]
18. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.
Wildum S; Zimmermann H; Lischka P
Antimicrob Agents Chemother; 2015; 59(6):3140-8. PubMed ID: 25779572
[TBL] [Abstract][Full Text] [Related]
20. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.
Michel D; Mertens T
Biochim Biophys Acta; 2004 Mar; 1697(1-2):169-80. PubMed ID: 15023359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]